Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sight Sciences's price to sales ratio was 7.2× on Nov 11, 2026, against 5.8× a year earlier. Over the last 5 years it ranged from 0.9× to 19.2×, with a median of 4.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.2× | +1.7 |
| 2025 | Dec 31, 2025 | 5.5× | +3.2 |
| 2024 | Dec 31, 2024 | 2.3× | −0.7 |
| 2023 | Dec 29, 2023 | 3.0× | −6.0 |
| 2022 | Dec 30, 2022 | 9.0× | −10.2 |
| 2021 | Dec 31, 2021 | 19.2× | – |
See a number that looks wrong?